Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG trial

Steven G. Pavlakis, Renée C. Rees, Xiangke Huang, R. Clark Brown, James F. Casella, Rathi V. Iyer, Ram Kalpatthi, Judy Luden, Scott T. Miller, Zora R. Rogers, Courtney D. Thornburg, Winfred C. Wang, Robert J. Adams

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


Background. Transcranial Doppler ultrasonography (TCD) is used to predict stroke risk in children with sickle cell anemia (SCA), but has not been adequately studied in children under age 2 years. Procedure. TCD was performed on infants with SCA enrolled in the BABY HUG trial. Subjects were 7-17 months of age (mean 12.6 months). TCD examinations were successfully performed in 94% of subjects (n=192). Results. No patient had an abnormal TCD as defined in the older child (time averaged maximum mean TAMM velocity ≥200 cm/sec) and only four subjects (2%) had velocities in the conditional range (170-199 cm/sec). TCD velocities were inversely related to hemoglobin (Hb) concentration and directly related to increasing age. Conclusion. Determination of whether the TCD values in this very young cohort of infants with SCA can be used to predict stroke risk later in childhood will require analysis of exit TCD's and long-term follow-up, which is ongoing ( number, NCT00006400).

Original languageEnglish (US)
Pages (from-to)256-259
Number of pages4
JournalPediatric Blood and Cancer
Issue number2
StatePublished - Feb 2010


  • Infant
  • Sickle cell anemia
  • Stroke
  • TCD
  • Transcranial doppler ultrasonography

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG trial'. Together they form a unique fingerprint.

Cite this